Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-20 4:16 pm Purchase | 2026-02-12 | 13G | NETSTREIT CORP NTST | Integrated Core Strategies (US) LLC | 5,246,726 5.400% | 3,255,378 (+163.48%) | Filing History |
| 2026-02-18 5:04 pm Purchase | 2026-02-11 | 13G | CABALETTA BIO INC CABA | Integrated Core Strategies (US) LLC | 5,130,763 5.300% | 5,130,763 (New Position) | Filing History |
| 2026-02-18 4:38 pm Purchase | 2026-02-11 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | Integrated Core Strategies (US) LLC | 3,281,615 5.700% | 245,492 (+8.09%) | Filing History |
| 2026-02-17 4:11 pm Sale | 2026-02-10 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Integrated Core Strategies (US) LLC | 887,274 4.800% | -19,488 (-2.15%) | Filing History |
| 2026-02-13 4:39 pm Sale | 2025-12-31 | 13G | VERMILION ENERGY INC VET | Integrated Core Strategies (US) LLC | 5,442,278 3.600% | -3,086,803 (-36.19%) | Filing History |
| 2026-02-12 4:18 pm Sale | 2025-12-31 | 13G | INVESCO LTD IVZ | Integrated Core Strategies (US) LLC | 21,848,486 4.900% | -4,308,567 (-16.47%) | Filing History |
| 2026-02-10 4:07 pm Purchase | 2026-02-03 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Integrated Core Strategies (US) LLC | 906,762 4.900% | 964 (+0.11%) | Filing History |
| 2026-02-06 4:51 pm Sale | 2026-01-30 | 13G | DAUCH CORPORATION DCH | Integrated Core Strategies (US) LLC | 1,561,814 0.700% | -5,837,587 (-78.89%) | Filing History |
| 2026-02-04 5:05 pm Sale | 2025-12-31 | 13G | FULGENT GENETICS INC FLGT | Integrated Core Strategies (US) LLC | 939,375 3.000% | -752,436 (-44.48%) | Filing History |
| 2026-02-04 4:14 pm Purchase | 2026-01-28 | 13G | COHEN CIRCLE ACQUISITION CORP CCII | Integrated Core Strategies (US) LLC | 1,324,919 5.100% | 1,324,919 (New Position) | Filing History |
| 2026-02-03 5:19 pm Purchase | 2026-01-28 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Integrated Core Strategies (US) LLC | 905,798 4.900% | 905,798 (New Position) | Filing History |
| 2026-02-03 4:31 pm Purchase | 2026-01-27 | 13G | GIGCAPITAL9 CORP UNIT & R GIXXU | Integrated Core Strategies (US) LLC | 1,175,000 4.600% | 1,175,000 (New Position) | Filing History |
| 2026-02-02 4:33 pm Purchase | 2026-01-26 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | Integrated Core Strategies (US) LLC | 3,036,123 5.300% | 3,036,123 (New Position) | Filing History |
| 2026-01-30 5:04 pm Purchase | 2026-01-23 | 13G | PRAETORIAN ACQU CORP USD UNITS PTORU | Integrated Core Strategies (US) LLC | 1,320,000 6.000% | 1,320,000 (New Position) | Filing History |
| 2026-01-29 5:21 pm Sale | 2025-12-31 | 13G | PYROPHYTE ACQUISITION CORP II PAII | Integrated Core Strategies (US) LLC | 775,000 3.900% | -348,100 (-30.99%) | Filing History |
| 2026-01-28 4:36 pm Purchase | 2026-01-21 | 13G | DAUCH CORPORATION DCH | Integrated Core Strategies (US) LLC | 7,399,401 6.200% | 4,060,330 (+121.60%) | Filing History |
| 2026-01-27 4:55 pm Sale | 2025-12-31 | 13G | HIGHVIEW MERGER CORP CL HVMC | Integrated Core Strategies (US) LLC | 999,996 4.200% | -350,004 (-25.93%) | Filing History |
| 2026-01-27 4:25 pm Sale | 2025-12-31 | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Integrated Core Strategies (US) LLC | 2,082,180 2.700% | -2,999,271 (-59.02%) | Filing History |
| 2026-01-21 4:28 pm Purchase | 2026-01-14 | 13G | BRAZE, INC. CLASS A BRZE | Integrated Core Strategies (US) LLC | 4,853,774 4.700% | 4,853,774 (New Position) | Filing History |
| 2026-01-16 4:16 pm Sale | 2025-12-31 | 13G | ANAPTYSBIO INC ANAB | Integrated Core Strategies (US) LLC | 1,220,356 2.900% | -919,984 (-42.98%) | Filing History |